QIAGEN at NGS Bioinformatics Challenge in Germany

QIAGEN had the pleasure of taking part in an NGS Bioinformatics Challenge run by the German Society for Pathology on the 9th and 10th of November in Halle, Germany. Three commercial organizations were supplied with vcf files from twelve samples sequenced using Illumina MiSeq™ Systems and the IonTorrent platform at Erlangen, Cologne Berlin. The identity of the know variants were withheld from all competing commercial informatics pipelines and the samples were supplied to each competitor one week before the meeting.

Susana Guedes represented QIAGEN at the NGS Bioinformatics Challenge and will demonstrate the process to result for one of the samples in this video. The analysis is performed using QIAGEN’s Clinical Insight-Interpret (QCI I), the NGS clinical decision support tool for variant interpretation and reporting.

QIAGEN’s Clinical Insight (QCI) has recently been updated to enable the automatic classification of somatic cancer alterations for actionability according to the AMP/ASCO/CAP interpretation and reporting guidelines!

Shibani Datta is a Global Market Manager in Demand Generation at QIAGEN. She has received her education in the field of Genetics from Texas A&M University, where she studied the mechanisms of DNA replication and amplification in Tetrahymena thermophila. Prior to her marketing role, she has trained as a biotechnologist in the field of assay development, antibody generation, and humanization. She is passionate about communicating the value of molecular technologies for research and healthcare.

Your email address will not be published. Required fields are marked *